NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

乾眼症症候群 (DES):流行病學的預測 (到2028年)

Dry Eye Syndrome: Epidemiology Forecast to 2028

出版商 GlobalData 商品編碼 941456
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
乾眼症症候群 (DES):流行病學的預測 (到2028年) Dry Eye Syndrome: Epidemiology Forecast to 2028
出版日期: 2020年05月30日內容資訊: 英文 35 Pages
簡介

全球主要8個國家的乾眼症症候群已受診患病人數,預計以年度平均1.21%的速度增加,2018年是1億4496萬2089人,2028年將達1億6246萬1992人。

本報告提供全球主要9個國家(美國,法國,德國,義大利,西班牙,英國,日本,中國,印度) 的乾眼症症候群 (DES)的發病情形與今後預測相關分析,疾病的特徵和目前患病者的發病情形,今後10年的發病數量/患病數量趨勢預測,男女、各症狀、各年齡詳細趨勢等調查。

目錄

第1章 目錄

第2章 乾眼症症候群:概要

第3章 流行病學

  • 疾病的背景
  • 危險因素與並存症
  • 全球過去趨勢
  • 預測手法
    • 資訊來源
    • 預測的前提條件與手法
    • 預測的前提條件與手法:總人口
    • 預測的前提條件與手法:DES的患病人數 (全體/已受診)
    • 預測的前提條件與手法:DES的患病人數 (全體/已受診),各重症度
  • 乾眼症症候群 (DES)的流行病學的預測(2018∼2028年)
    • 乾眼症症候群 (DES)的已受診患病人數
    • 乾眼症症候群 (DES)的已受診患病人數:各年齡 (18歲以上/以下)
    • 乾眼症症候群 (DES)的已受診患病人數:男女
    • 乾眼症症候群 (DES)的已受診患病人數:各重症度 (小病,中症,重病)
    • 乾眼症症候群 (DES)的患病者的總數
    • 乾眼症症候群 (DES)的患病者的總數:各重症度
  • 討論
    • 流行病學的預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCER241-20

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye characterized by dryness, decreased tear production, or increased tear film evaporation. Patients with DES experience symptoms of discomfort, such as visual disturbance and tear film instability (Lemp and Foulks, 2007). Middle-aged and elderly people are most commonly affected because of the high prevalence of contact lens usage, systemic drug effects, autoimmune diseases, and refractive surgeries (Toda et al., 2001; Schaumberg, Sullivan and Dana, 2002; Glasson et al., 2003; Schaumberg et al., 2003).

GlobalData epidemiologists utilized historical data obtained from peer-reviewed articles and reports to build the forecast for the total and the diagnosed prevalent cases of DES in the 9MM. GlobalData epidemiologists applied the prevalence of DES drawn from the above sources to each country's population to calculate the number of estimated diagnosed prevalent cases for DES.

The following data describes the epidemiology of DES. In the 9MM, GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of DES from 144,962,089 cases in 2018 to 162,461,992 cases in 2028, at an Annual Growth Rate (AGR) of 1.21%. In 2028, China will have the highest number of diagnosed prevalent cases of DES in the 9MM, with 61,680,272 diagnosed prevalent cases, and whereas Spain will have the fewest diagnosed prevalent cases with 1,855,079 cases. In the 9MM, the total prevalent cases of DES are expected to increase from 417,103,544 cases in 2018 to 466,531,434 cases in 2028, at an AGR of 1.19%.

Scope

  • The Dry Eye Syndrome Epidemiology Report provides an overview of the risk factors and global trends of Dry Eye Syndrome(DES) in the nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).
  • The report includes a 10-year epidemiology forecast for the diagnosed prevalent and total prevalent cases (including both diagnosed and undiagnosed cases) of DES.
  • The diagnosed prevalent cases of DES are segmented by sex, severity (mild, moderate, and severe), and age (18 years and older).
  • The total prevalent cases of DES are segmented by severity (mild, moderate, and severe).
  • The DES epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to Buy

  • The DES Epidemiology series will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global DES markets.
  • Quantify patient populations in the global DES markets to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DES therapeutics in each of the markets covered.
  • Understand magnitude of DES population by its severity.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Dry Eye Syndrome: Executive Summary

  • 2.1 Catalyst
  • 2.2 Related Reports
  • 2.3 Upcoming Reports

3 Epidemiology

  • 3.1 Disease Background
  • 3.2 Risk Factors and Comorbidities
  • 3.3 Global and Historical Trends
  • 3.4 Forecast Methodology
    • 3.4.1 Sources Used
    • 3.4.2 Forecast Assumptions and Methods
    • 3.4.3 Forecast Assumptions and Methods - Total and Diagnosed Prevalent Cases of DES
    • 3.4.4 Forecast Assumptions and Methods - Total and Diagnosed Prevalent Cases of DES by Severity
  • 3.5 Epidemiological Forecast for DES (2018-2028)
    • 3.5.1 Diagnosed Prevalent Cases of DES
    • 3.5.2 Age-Specific Diagnosed Prevalent Cases of DES
    • 3.5.3 Sex-Specific Diagnosed Prevalent Cases of DES
    • 3.5.4 Diagnosed Prevalent Cases of DES by Severity
    • 3.5.5 Total Prevalent Cases of DES
    • 3.5.6 Total Prevalent Cases of DES by Severity
  • 3.6 Discussion
    • 3.6.1 Epidemiological Forecast Insight
    • 3.6.2 Limitations of the Analysis
    • 3.6.3 Strengths of the Analysis

4 Appendix

  • 4.1 Bibliography
  • 4.2 About the Authors
    • 4.2.1 Epidemiologist
    • 4.2.2 Reviewers
    • 4.2.3 Global Director of Therapy Analysis and Epidemiology
    • 4.2.4 Global Head and EVP of Healthcare Operations and Strategy
  • 4.3 About GlobalData
  • 4.4 Contact Us
  • 4.5 Disclaimer

List of Tables

  • Table 1: Summary of Newly Added Data Types
  • Table 2: Summary of Updated Data Types
  • Table 3: Risk Factors and Comorbidities for DES

List of Figures

  • Figure 1: 9MM, Diagnosed Prevalent Cases of DES, Both Sexes, N, Ages ≥18 Years, 2018 and 2028
  • Figure 2: 9MM, Total Prevalent Cases of DES, Both Sexes, N, Ages ≥18 Years, 2018 and 2028
  • Figure 3: 9MM, Diagnosed Prevalence of DES, Men and Wom